发药啦精品
Published by:
Gansu Tianjian PharmaceuticalLtd
Description
发药啦精品是甘肃天健医药有限公司为相关业务部门和人员打造的一个工作商务沟通、协同移动办公应用，用以提升办公效率，实现数字化办公
Screenshots
发药啦精品 FAQ
-
Is 发药啦精品 free?
Yes, 发药啦精品 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 发药啦精品 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 发药啦精品 cost?
发药啦精品 is free.
-
What is 发药啦精品 revenue?
To get estimated revenue of 发药啦精品 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History
发药啦精品 Reviews
No Reviews in Hong Kong SAR China
App doesn't have any reviews in Hong Kong SAR China yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
发药啦精品 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
恩长健
让更多人的人用上更好的药材
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
众联蒲公英
|
Unlock
|
Unlock
|
0
|
|
8 months ago | |
广奕控销
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
云红控销
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
天瑞控销部
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
N/A
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
同悦康
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
全泰堂
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
明药汇
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
施可韦易采
|
Unlock
|
Unlock
|
0
|
|
3 months ago |
发药啦精品 Installs
Last 30 days
发药啦精品 Revenue
Last 30 days发药啦精品 Revenue and Downloads
Gain valuable insights into 发药啦精品 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Shopping
- Publisher
-
Gansu Tianjian PharmaceuticalLtd
- Languages
- English
- Recent release
- 1.1.3 (1 year ago )
- Released on
- Jul 9, 2021 (3 years ago )
- Also available in
- China , Hong Kong SAR China , United States
- Last Updated
- 1 hour ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.